Anxo Pharmaceutical Co., Ltd. (TPEX:6677)
Taiwan · Delayed Price · Currency is TWD 16.60
0.00 (0.00%)
Aug 19, 2026, 1:36 PM CST
Anxo Pharmaceutical Market Cap
Anxo Pharmaceutical has a market cap or net worth of 893.94 million as of August 19, 2026. Its market cap has decreased by -23.44% in one year.
Market Cap
893.94M
Enterprise Value
1.42B
Revenue
878.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.60
ChartMarket Cap Chart
Since June 27, 2018, Anxo Pharmaceutical's market cap has decreased from 2.16B to 893.94M, a decrease of -58.57%. That is a compound annual growth rate of -10.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 927.46M | -11.47% |
| Dec 31, 2025 | 1.05B | -21.58% |
| Dec 31, 2024 | 1.34B | -50.67% |
| Dec 29, 2023 | 2.71B | 89.95% |
| Dec 30, 2022 | 1.43B | 20.33% |
| Dec 30, 2021 | 1.18B | -13.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TSH Biopharm Corporation | 1.94B |
| GeneFerm Biotechnology | 1.25B |
| InnoPharmax | 1.23B |
| Excelsior Biopharma | 1.15B |
| Prince Pharmaceutical | 1.09B |
| DV Biomed | 1.02B |
| Original BioMedicals | 942.23M |
| Winston Medical Supply | 920.85M |